Trexquant Investment’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-32,930
| Closed | -$838K | – | 1552 |
|
2024
Q3 | $838K | Buy |
+32,930
| New | +$838K | 0.01% | 1102 |
|
2023
Q4 | – | Sell |
-9,216
| Closed | -$243K | – | 1428 |
|
2023
Q3 | $243K | Buy |
+9,216
| New | +$243K | 0.01% | 1294 |
|
2023
Q1 | – | Sell |
-143,067
| Closed | -$1.09M | – | 1440 |
|
2022
Q4 | $1.09M | Sell |
143,067
-11,023
| -7% | -$84K | 0.03% | 615 |
|
2022
Q3 | $1.53M | Buy |
154,090
+91,210
| +145% | +$907K | 0.05% | 410 |
|
2022
Q2 | $571K | Buy |
+62,880
| New | +$571K | 0.03% | 753 |
|
2021
Q4 | – | Sell |
-29,204
| Closed | -$1.37M | – | 1292 |
|
2021
Q3 | $1.37M | Buy |
29,204
+22,638
| +345% | +$1.06M | 0.11% | 252 |
|
2021
Q2 | $400K | Buy |
6,566
+1,696
| +35% | +$103K | 0.03% | 590 |
|
2021
Q1 | $300K | Buy |
+4,870
| New | +$300K | 0.03% | 749 |
|
2020
Q4 | – | Sell |
-12,906
| Closed | -$484K | – | 1025 |
|
2020
Q3 | $484K | Sell |
12,906
-8,812
| -41% | -$330K | 0.03% | 702 |
|
2020
Q2 | $708K | Buy |
+21,718
| New | +$708K | 0.05% | 533 |
|